Related Experiment Video
Updated: Oct 3, 2025
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
[Extension of HPV vaccination to boys: Survey of families and general practitioners]
Sarah Derhy1, Julie Gaillot1, Sophie Rousseau1
1Institut national du cancer, département prévention, 52, avenue André-Morizet, 92100 Boulogne-Billancourt, France.
Insights
Extending human papillomavirus (HPV) vaccination to boys is supported by most general practitioners (GPs). However, parental concerns about side effects and lack of information remain barriers to HPV vaccine uptake.
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- Analysis of extending the human papillomavirus (HPV) vaccination to French boys.
- Survey conducted by the French National Cancer Institute (INCa) and the French National Authority for Health (HAS) in July 2019.
- Investigated parental and general practitioner (GP) acceptance of HPV vaccination for boys.
Purpose of the Study:
- To assess parental and GP attitudes towards HPV vaccination.
- To identify barriers to HPV vaccine acceptance among parents.
- To evaluate the potential impact of extending HPV vaccination to boys in France.
Main Methods:
- Web-based questionnaire survey conducted from June 20 to July 12, 2019.
- Nationally representative sample of 1984 parents with children aged 11-19.
- Representative sample of general practitioners (GPs) in mainland France.
Main Results:
- 94% of GPs favored HPV vaccination, but 82% found parental adherence challenging.
- 25% of parents held unfavorable opinions regarding HPV vaccination.
- Key parental barriers: fear of adverse effects, insufficient information, and lack of GP recommendation.
Conclusions:
- 84% of GPs would recommend HPV vaccination to boys if included in the schedule.
- 88% of GPs not routinely recommending HPV vaccine to girls would be more likely to offer it if the extension to boys was recommended.
- Policy changes and addressing parental concerns are crucial for successful HPV vaccination program expansion.
Introduction:
As part of an analysis on the extension of the HPV vaccination to French boys, the French National Cancer Institute (INCa) and the French National Authority for Health (HAS) have conducted in collaboration a survey on HPV vaccine acceptance in July 2019. This survey was completed by parents of children aged 11-19 and general practitioners (GPs). Questions focused on their representations, practices and intentions in the context of the future policy change allowing boys to get vaccinated against HPV.
Methods:
The survey was conducted between June 20 and July 12, 2019. It focused on two populations: a nationally representative sample of parents with at least one girl aged 11-19 and/or one boy aged 11-14 (n=1984) and a representative sample of GPs in mainland France. Data were collected through a web-based questionnaire with a mean completion time of 10minutes for parents and GPs. The quota method was applied to ensure the representative nature of the samples based on (i) gender, age, children (girl aged 11-14 and/or boy aged 11-14) of the household, socio-professional category of the "head of the household", size of urban area and region for the parents' sample and based on (ii) gender, age, region and type of practice for the GPs' sample.
Results:
Although most GPs were very favourable towards HPV vaccination (94%), they considered it one of the most challenging vaccinations to get parents to adhere to (82%). A notable percentage of parents have unfavourable opinions towards HPV vaccination (25%). The three main barriers cited by parents of non-vaccinated girls were: the fear of adverse effects, the lack of information, and the fact that the GP did not propose it. Regarding the extension of HPV vaccination to boys, 84 % of GPs would recommend this vaccination to boys if it was included in the vaccination schedule, and 88 % of those who did not routinely recommend HPV vaccination to girls would be more likely to offer it to girls if the extension was recommended.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
01:51Vaccinations
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:20Longitudinal Research
02:59Cancer Prevention
Some...
01:30Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:30Preventive Healthcare Services